On Tuesday, Alx Oncology Holdings Inc (NASDAQ: ALXO) opened lower -13.27% from the last session, before settling in for the closing price of $2.11. Price fluctuations for ALXO have ranged from $0.40 to $2.27 over the past 52 weeks.
A company in the Healthcare sector has dropped its sales by -32.29% annually for the last half of the decade. Company’s average yearly earnings per share was noted 32.69% at the time writing. With a float of $37.29 million, this company’s outstanding shares have now reached $53.51 million.
Alx Oncology Holdings Inc (ALXO) Insider Updates
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Alx Oncology Holdings Inc is 30.37%, while institutional ownership is 36.20%. The most recent insider transaction that took place on Sep 17 ’25, was worth 76,892. In this transaction CHIEF EXECUTIVE OFFICER of this company bought 71,163 shares at a rate of $1.08, taking the stock ownership to the 305,121 shares. Before that another transaction happened on Sep 16 ’25, when Company’s CHIEF EXECUTIVE OFFICER bought 21,070 for $1.07, making the entire transaction worth $22,461. This insider now owns 233,958 shares in total.
Alx Oncology Holdings Inc (ALXO) Performance Highlights and Predictions
If we go through the results of last quarter, which was made public on 9/30/2024, the company posted -0.58 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -0.66) by 0.07. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.33 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 32.69% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 29.09% during the next five years compared to -32.29% drop over the previous five years of trading.
Alx Oncology Holdings Inc (NASDAQ: ALXO) Trading Performance Indicators
Check out the current performance indicators for Alx Oncology Holdings Inc (ALXO). In the past quarter, the stock posted a quick ratio of 4.52. For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.20, a number that is poised to hit -0.37 in the next quarter and is forecasted to reach -1.06 in one year’s time.
Technical Analysis of Alx Oncology Holdings Inc (ALXO)
Let’s dig in a bit further. During the last 5-days, its volume was 0.7 million. That was inferior than the volume of 0.84 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 73.11%.
During the past 100 days, Alx Oncology Holdings Inc’s (ALXO) raw stochastic average was set at 76.42%, which indicates a significant increase from 64.52% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.20 in the past 14 days, which was higher than the 0.09 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.12, while its 200-day Moving Average is $0.92. However, in the short run, Alx Oncology Holdings Inc’s stock first resistance to watch stands at $2.04. Second resistance stands at $2.26. The third major resistance level sits at $2.37. If the price goes on to break the first support level at $1.71, it is likely to go to the next support level at $1.60. Assuming the price breaks the second support level, the third support level stands at $1.38.
Alx Oncology Holdings Inc (NASDAQ: ALXO) Key Stats
There are currently 53,551K shares outstanding in the company with a market cap of 98.00 million. Presently, the company’s annual sales total 0 K according to its annual income of -134,850 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -25,950 K.
